National, Multicenter, Randomized, Double-blind, Pilot Study to Evaluate the Efficacy and Safety of BNP105 in the Treatment of Recurrent Aphthous Stomatitis
Latest Information Update: 23 Feb 2024
At a glance
- Drugs BNP 105 (Primary)
- Indications Aphthous stomatitis
- Focus Therapeutic Use
- Sponsors EMS
Most Recent Events
- 15 Feb 2024 Planned End Date changed from 1 Dec 2025 to 1 Apr 2025.
- 15 Feb 2024 Planned primary completion date changed from 1 Oct 2024 to 1 Jan 2025.
- 15 Feb 2024 Status changed from not yet recruiting to recruiting.